Valuation: QuidelOrtho Corporation

Market Cap 1.01B 866M 810M 742M 1.39B 96.71B 1.41B 9.57B 3.73B 48.58B 3.8B 3.71B 161B P/E 2026 *
-3.58x
P/E 2027 * -5.32x
Enterprise Value 3.72B 3.19B 2.98B 2.73B 5.13B 356B 5.2B 35.26B 13.75B 179B 13.98B 13.68B 592B EV / Sales 2026 *
1.46x
EV / Sales 2027 * 1.4x
Free-Float
99.11%
Yield 2026 *
-
Yield 2027 * -
1 day-0.74%
1 week+3.08%
Current month-12.10%
1 month-11.63%
3 months+24.28%
6 months-34.43%
Current year-48.39%
1 week 13.2
Extreme 13.205
15.5
1 month 11.41
Extreme 11.41
18.04
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
84.6
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
8/15/26 Fiscal year

EVP Global Port. Mgmt & Mkting

1,054 0.0016%
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%+3.08%-47.17%-81.88% 1.01B
-0.84%+3.92%+25.85%-29.38% 17.87B
-3.05%-7.40%-35.21%+92.83% 1.64B
+1.26%+0.44%-21.91%+26.08% 997M
+0.11%+0.11%+59.29%-6.98% 780M
-2.29%-1.45%-36.88%-46.39% 689M
-1.91%-12.67%-43.70%-46.81% 566M
+3.23%+2.36%-40.40%-35.27% 457M
+3.19%+6.69%+65.58%+47.72% 441M
+0.86%+7.07%-9.91%-8.50% 412M
Average -0.02%-0.03%-8.45%-8.86% 2.49B
Weighted average by Cap. -0.76%+2.31%+13.57%-19.81%

Financials

2026 *2027 *
Net sales 2.54B 2.18B 2.04B 1.87B 3.5B 243B 3.55B 24.09B 9.4B 122B 9.55B 9.35B 405B 2.59B 2.22B 2.08B 1.9B 3.57B 248B 3.62B 24.54B 9.57B 125B 9.73B 9.52B 412B
Net income -282M -241M -226M -207M -388M -26.94B -393M -2.67B -1.04B -13.53B -1.06B -1.03B -44.76B -191M -164M -153M -140M -263M -18.26B -266M -1.81B -705M -9.17B -717M -701M -30.35B
Net Debt 2.71B 2.32B 2.17B 1.99B 3.74B 260B 3.78B 25.69B 10.02B 130B 10.19B 9.97B 431B 2.62B 2.25B 2.1B 1.93B 3.61B 251B 3.66B 24.85B 9.69B 126B 9.85B 9.64B 417B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-08-21 US$14.74 -0.74% 2,022,153
26-08-20 US$14.85 +7.61% 2,508,016
26-08-19 US$13.80 +2.76% 1,315,285
26-08-18 US$13.43 -7.89% 1,378,643
26-08-17 US$14.58 +1.96% 1,236,150
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
14.74USD
Average target price
14.67USD
Spread / Average Target
-0.50%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock